RT Journal Article
SR Electronic
T1 CLINICAL AND DEMOGRAPHIC CHARACTERISTICS OF COVID-19 PATIENTS IN LAGOS, NIGERIA: A DESCRIPTIVE STUDY
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.09.15.20195412
DO 10.1101/2020.09.15.20195412
A1 Otuonye, Ngozi Mirabel
A1 Olumade, Testimony Jesupamilerin
A1 Ojetunde, Mercy Mayowa
A1 Holdbrooke, Susan Abba
A1 Ayoola, Joy Boluwatife
A1 Nyam, Itse Yusuf
A1 Iwalokun, Bamidele
A1 Onwuamah, Chika
A1 Uwandu, Mabel
A1 Salako, Babatunde Lawal
A1 Abayomi, Akinola
A1 Osibogun, Akin
A1 Bowale, Abimbola
A1 Osikomaiya, Bodunrin
A1 Thomas, Babafemi
A1 Mutiu, Bamidele
A1 Odunukwe, Nkiruka Nnonyelum
YR 2020
UL http://medrxiv.org/content/early/2020/09/24/2020.09.15.20195412.abstract
AB Introduction COVID-19 is an emerging, rapidly evolving global situation, infecting over 25 million people and causing more than 850,000 deaths. Several signs and symptoms have been described to be characteristic of the disease. However, there is a dearth of report on the description of the clinical characteristics of the disease in patients from Nigeria. This study was designed to provide a description of the clinical and demographic characteristics of COVID-19 patients in Nigeria.Methods This study is a case series that includes patients that are evaluated between June and August 30, 2020, and diagnosed with COVID-19. Patient health records were reviewed and evaluated to describe the clinical characteristics on presentation.Results A total of 154 COVID-19 patients were included in this study, with a mean age (S.D.) of 46.16 (13.701). Most of the patients survived (mortality rate of 2.6%), and were symptomatic (89.6%). There were more males (74.7%) than females, and the most common symptoms were fever, breathing difficulty, dry cough and malaise. Co-morbidities were also present in almost half of the study participants (49.4%).Conclusion This study presents the most extensive description, to date, on the clinical and demographic characteristics of COVID-19 patients in Nigeria. Males are more likely than females to be infected with COVID-19 and the most occurring symptoms are fever, breathing difficulty, malaise, dry cough and chest pain. Old age and the presence of co-morbidities may also be associated with developing the severe disease.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThe PI and co-authors financed this studyAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Nigerian Institute of Medical Research (NIMR) Institutional Review Board (IRB), Yaba, Lagos, Nigeria.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesBesides those presented in the study, there are no other supporting data for this manuscript.